Cargando…

Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic

Health system disruption caused by the COVID-19 pandemic prompted public health professionals to reevaluate potential barriers and opportunities to community pharmacist provision of chronic disease management services and to identify opportunities for maximizing community pharmacists’ impact. Resear...

Descripción completa

Detalles Bibliográficos
Autores principales: Dwyer, Gregory, Popoola, Adebola, Seiler, Naomi, Therrien, Nicole, Karacuschansky, Aaron, Fulmer, Erika, Horton, Katie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8937620/
https://www.ncbi.nlm.nih.gov/pubmed/35239471
http://dx.doi.org/10.5888/pcd19.210280
_version_ 1784672383024496640
author Dwyer, Gregory
Popoola, Adebola
Seiler, Naomi
Therrien, Nicole
Karacuschansky, Aaron
Fulmer, Erika
Horton, Katie
author_facet Dwyer, Gregory
Popoola, Adebola
Seiler, Naomi
Therrien, Nicole
Karacuschansky, Aaron
Fulmer, Erika
Horton, Katie
author_sort Dwyer, Gregory
collection PubMed
description Health system disruption caused by the COVID-19 pandemic prompted public health professionals to reevaluate potential barriers and opportunities to community pharmacist provision of chronic disease management services and to identify opportunities for maximizing community pharmacists’ impact. Researchers conducted semistructured interviews with representatives from chronic disease prevention and pharmacy practice and policy organizations to identify key themes across multiple interviews and novel responses of interest. Interviewees described a lack of payment models to support pharmacist-provided chronic disease management services but noted opportunities for community pharmacists to demonstrate their value in offering services they are uniquely positioned to provide and to implement better workflow solutions. Successfully demonstrating pharmacists’ value and making the case for reimbursement from payors, as well as optimizing pharmacy workflow, are critical to maximizing pharmacists’ impact in chronic disease prevention and management.
format Online
Article
Text
id pubmed-8937620
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-89376202022-03-31 Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic Dwyer, Gregory Popoola, Adebola Seiler, Naomi Therrien, Nicole Karacuschansky, Aaron Fulmer, Erika Horton, Katie Prev Chronic Dis Research Brief Health system disruption caused by the COVID-19 pandemic prompted public health professionals to reevaluate potential barriers and opportunities to community pharmacist provision of chronic disease management services and to identify opportunities for maximizing community pharmacists’ impact. Researchers conducted semistructured interviews with representatives from chronic disease prevention and pharmacy practice and policy organizations to identify key themes across multiple interviews and novel responses of interest. Interviewees described a lack of payment models to support pharmacist-provided chronic disease management services but noted opportunities for community pharmacists to demonstrate their value in offering services they are uniquely positioned to provide and to implement better workflow solutions. Successfully demonstrating pharmacists’ value and making the case for reimbursement from payors, as well as optimizing pharmacy workflow, are critical to maximizing pharmacists’ impact in chronic disease prevention and management. Centers for Disease Control and Prevention 2022-03-03 /pmc/articles/PMC8937620/ /pubmed/35239471 http://dx.doi.org/10.5888/pcd19.210280 Text en https://creativecommons.org/licenses/by/4.0/Preventing Chronic Disease is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Brief
Dwyer, Gregory
Popoola, Adebola
Seiler, Naomi
Therrien, Nicole
Karacuschansky, Aaron
Fulmer, Erika
Horton, Katie
Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic
title Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic
title_full Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic
title_fullStr Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic
title_full_unstemmed Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic
title_short Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic
title_sort chronic disease management service opportunities for community pharmacists during the covid-19 pandemic
topic Research Brief
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8937620/
https://www.ncbi.nlm.nih.gov/pubmed/35239471
http://dx.doi.org/10.5888/pcd19.210280
work_keys_str_mv AT dwyergregory chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic
AT popoolaadebola chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic
AT seilernaomi chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic
AT therriennicole chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic
AT karacuschanskyaaron chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic
AT fulmererika chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic
AT hortonkatie chronicdiseasemanagementserviceopportunitiesforcommunitypharmacistsduringthecovid19pandemic